Basic info
Industry
biotechnology research
Sectors
Serum biomarker signatures
Biotechnology
prognosis and therapy monitoring
Clinical Trials
Autoimmune diseases diagnosis
Health Diagnostics
Early diagnosis of cancer
Patient classification
Pancreatic cancer
Cancer therapy monitoring
Blood-based tests
Antibody microarray technology
Date founded
2007
Funding rounds raised
Total raised
$4.6M
from 1 investors over 1 rounds
I
Immunovia AB raised $4.6M on June 1, 2015
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)